Pfizer explored a potential tax-lowering takeover of rival Actavis in recent weeks, but talks between the two pharmaceutical companies have ended, according to a person familiar with the matter.
from WSJ.com: US Business http://ift.tt/1xbnO60
via IFTTT
from WSJ.com: US Business http://ift.tt/1xbnO60
via IFTTT
No comments:
Post a Comment